Top Markets
Coin of the day
GlycoNex Incorporation GlycoNex Incorporation

GlycoNex Incorporation

4168
Hisse Senetlerindeki Sıralama #22943
GlycoNex Incorporation, based in New Taipei City, Taiwan, specializes in... GlycoNex Incorporation, based in New Taipei City, Taiwan, specializes in developing innovative cancer therapeutics. The company achieves this by leveraging advanced glycosphingolipid antigen and human monoclonal antibody technologies. Its robust pipeline for solid tumors features several investigational antibody drugs. These include GNX102, a humanized monoclonal antibody currently in Phase 1 clinical trials; GNX201, an antibody candidate undergoing lead optimization; and GNX202, which is in preclinical development. Additionally, GNX203 and GNX204 are antibody drugs presently in the target validation stage. Beyond oncology, GlycoNex is also advancing other therapeutic agents. This includes SPD (Denosumab), a humanized IgG2 antibody in preclinical stages for both osteoporosis and oncology indications. Another key asset is SEA (Aflibercept), a vascular endothelial growth factor (VEGF) binding fusion protein, currently undergoing lead optimization for its potential use in ophthalmology and oncology. GlycoNex was established in 2001.
Hisse Fiyatı
$0.71865803
Son senkronizasyon: 2026-08-21
Piyasa Değeri
$80.86M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-5.48%
Ülke
TW
Ticaret GlycoNex Incorporation (4168)

Kategori

GlycoNex Incorporation (4168) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.72 - 2026-08-01

Gün sonu en düşük fiyat: $2.55 - 2012-06-01
GlycoNex Incorporation için hisse fiyatı geçmişi: 2012 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 4.61%
2025 -1.85%
2024 -14.27%
2023 -16.58%
2022 0.65%
2021 19.55%
2020 36.23%
2019 -14.54%
2018 0.91%
2017 -26.75%
2016 -41.27%
2015 -21.61%
2014 -32.30%
2013 -27.14%
2012 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH